Literature DB >> 1707658

All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

H Masmoudi1, T Mota-Santos, F Huetz, A Coutinho, P A Cazenave.   

Abstract

After adult irradiation and reconstitution with autologous bone marrow, BALB/c and C.B20 mice no longer utilize the T15 Id in response to phosphorylcholine. T15 Id expression can be restored by transfers of peritoneal B cells or by FACS-purified CD5+ IgM+ lymphocytes (but not by T lymphocytes) from syngeneic donors. Using bone marrow and peritoneal cell donors that are congeneic for heavy and light chain allotypes, the exclusive origin of the T15 Id in peritoneal B cells was ascertained. These conclusions have been essentially confirmed by immunization with either anti-T15 Id or anti-VHT15 antibodies conjugated to lipopolysaccharide. Thus, the production of VHT15-positive antibodies continues at control levels in bone marrow-reconstituted animals while no T15 Id production can be stimulated even in this protocol of direct B cell stimulation. These results constitute the first formal demonstration of the exclusive production of and Id by CD5+ B-cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707658     DOI: 10.1093/intimm/2.6.515

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  76 in total

Review 1.  Immune recognition of OxLDL in atherosclerosis.

Authors:  J F Kearney
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 2.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra; H Ishida; R de Waal Malefyt; J de Vries
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

3.  B1a lymphocytes in the rectal mucosa of ulcerative colitis patients.

Authors:  Lino Polese; Riccardo Boetto; Giuseppe De Franchis; Imerio Angriman; Andrea Porzionato; Lorenzo Norberto; Giacomo Carlo Sturniolo; Veronica Macchi; Raffaele De Caro; Stefano Merigliano
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

4.  Antigen-specific antibody responses in B-1a and their relationship to natural immunity.

Authors:  Yang Yang; Eliver Eid Bou Ghosn; Leah E Cole; Tetyana V Obukhanych; Patricia Sadate-Ngatchou; Stefanie N Vogel; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

5.  B-1 cells in the bone marrow are a significant source of natural IgM.

Authors:  Youn Soo Choi; Jacquelyn A Dieter; Kristina Rothaeusler; Zheng Luo; Nicole Baumgarth
Journal:  Eur J Immunol       Date:  2011-11-28       Impact factor: 5.532

Review 6.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

7.  B1a lymphocytes in ulcerative colitis.

Authors:  Lino Polese; Giuseppe De Franchis; Marco Scarpa; Giacomo C Sturniolo; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide F D'Amico; Imerio Angriman
Journal:  Int J Colorectal Dis       Date:  2007-03-20       Impact factor: 2.571

8.  Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes.

Authors:  Teresita L Arenzana; Matthew R Smith-Raska; Boris Reizis
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

9.  Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.

Authors:  Rosa Catera; Gregg J Silverman; Katerina Hatzi; Till Seiler; Sebastien Didier; Lu Zhang; Maxime Hervé; Eric Meffre; David G Oscier; Helen Vlassara; R Hal Scofield; Yifang Chen; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2008-09-25       Impact factor: 6.354

10.  Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Authors:  Daiju Ichikawa; Masanao Asano; Susan A Shinton; Joni Brill-Dashoff; Anthony M Formica; Anna Velcich; Richard R Hardy; Kyoko Hayakawa
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.